Home ABOUT Board of Directors

Board of Directors

Medigus' Board of Directors combines experienced executives with extensive background in managing and developing emerging companies.

Medigus' Board of Directors is comprised of reputable people with broad business experience in the financial and medical device markets.

Dr. Nissim Darvish Chairman of the Board

Dr. Nissim Darvish

Chairman of the Board
Dr. Darvish is a Senior Managing Director at OrbiMed.

Read more...

Ms. Anat Naschitz Director

Ms. Anat Naschitz

Director
Ms. Naschitz is a Managing Director at OrbiMed.

Read more...

Mr. Erez Chimovits Director

Mr. Erez Chimovits

Director
Mr. Chimovits is a Managing Director at Orbimed.

Read more...

Mr. Ori Hershkovitz External Director

Mr. Ori Hershkovitz

External Director
Mr. Hershkovitz has extensive experience in the financial sector and capital markets. He has been an analyst at Ilanot-Batucha and Leaderim Capital Markets.

Read more...

Yair Rabionowitch Chairman

Mr. Yair Rabinowitch

Director
Former Managing Partner of Bavly & Co (KPMG--Israel), Mr. Rabinowitch, is the former commissioner of the Israeli IRS and an expert in tax and legal matters.

Read more...

Mr. Chris Rowland Director

Mr. Chris Rowland

Director
Chris joined IntraPace Inc. (www.intrapace.com) in January 2012 and is the President and CEO of the company..

Read more...

Dr. Gabi Sarusi External Director

Prof. Gabi Sarusi

External Director
Prof. Sarusi has extensive experience in the medical device industry. Prof. Sarusi holds several positions, including VP Business Development and Chief Scientist at El-Op Electro-Optic Industries Ltd.

Read more...

Medigus

Medigus is a medical device company specializing in developing innovative endoscopic procedures and devices, including the revolutionary disposable endoscope for the treatment of GERD (Gastroesophageal Reflux Disease).

The company, which was founded in January 2000, is based in Israel and is publicly traded on the TASE. Medigus owns a unique and outstanding technological platform enabling the company to bring into the world state-of-the-art medical device products.

Read more

News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Prev Next

EAES European Association for Endoscopic Surgery

21-05-2013

June 19-22, 2013
Vienna, Austria
Visit us at booth #25

Read more

Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando

16-05-2013

Medigus Ltd. (MDGS.TA), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up da...

Read more

DDW Digestive Disease Week

06-05-2013

May 18-21, 2013
Orlando, Florida

Read more

Successful five-year follow-up data from SRS™ pilot study

05-05-2013

Medigus (TASE:MDGS) announced today that it had received five-year follow-up results of a pilot study of its SRS™ endoscopic system for the treatment of Gastroesophageal Reflux Disease (GERD). The ...

Read more

Medigus Signed a Distribution Agreement in China

12-03-2013

Local distributor to purchase SRS™II systems for a minimum of $3.85 million.

Read more

Medigus completed $8M private placement by OrbiMed

04-03-2013

Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed ...

Read more

Columbia Medical Center Offers SRS Procedures

13-02-2013

Medigus (TASE:MDGS) announces that Columbia University Medical Center, Department of Surgery (New-York, New-York), now offers the SRS™ procedure for transoral incisionless treatment of GERD.

Read more

Medigus announces an exclusive distribution agreement for the SRS™II in Turkey

16-01-2013

Medigus (TASE:MDGS) announces an exclusive distribution agreement for the SRS™II in Turkey.

Read more
youtube Linked In
© All rights reserved to Medigus Ltd 2008-2012